Spyre Therapeutics (SYRE) Q4 2025 Earnings

4NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.99
-0.71
-0.43
-0.15

Details

Expected EPS
-0.760757
Actual EPS
-0.15
Surprise EPS
0.61
Surprise Percent
+80.28%

Description

Spyre Therapeutics (SYRE) has reported earnings of -0.15 per share for Q4 2025.

0 Comments

Share your thoughts